Modulation of GABAA receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis‐9,10‐octadecenoamide (cOA)
- 1 July 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 124 (5) , 873-882
- https://doi.org/10.1038/sj.bjp.0701918
Abstract
1. Cis-9,10-octadecenoamide (cOA) accumulates in the CSF of sleep-deprived cats and may represent a novel signalling molecule. Synthetic cOA has been shown to induce physiological sleep when injected into laboratory rats. Here we assess the cellular mode of action of cOA in vitro. 2. In all rat cultured cortical neurones (pyramidal cells) examined, the synthetic brain lipid (3.2-64 microM) enhanced the responses to subsaturating GABA concentrations (up to circa 2x) in a concentration-dependent manner (EC50, circa 15 microM). 3. (20 microM) cOA significantly enhanced the affinity of exogenous GABA for its receptor without changing the Hill slope or the maximal response. These effects were not voltage-dependent or secondary to shifts in E(Cl). 4. In the absence of GABA, cOA directly evoked small inhibitory currents in a subpopulation (<7%) of sensitive cells. 5. 20 microM cOA reversibly enhanced the duration of spontaneous inhibitory post synaptic currents (circa 2 fold) without significantly altering their amplitude. 6. At 32-64 microM, cOA reversibly reduced the incidence and amplitude of both inhibitory post synaptic currents (i.p.s.cs) and excitatory post synaptic currents (e.p.s.cs) in the cultured neuronal circuits in common with other depressant drugs acting at the GABA(A) receptor. 7. 32 microM Oleic acid did not modulate exogenous GABA currents or synaptic activity suggesting that cOAs actions are mediated through a specific receptor. 8. A specific, protein-dependent interaction with GABA(A) receptors was confirmed in Xenopus oocytes. Recombinant human receptors were modulated by 10 microM cOA (and diazepam) only when a gamma2 subunit was co-expressed with alpha1beta2: the cOA response was not sensitive to the specific benzodiazepine antagonist flumazenil (1 microM). 9. cOA may represent an endogenous ligand for allosteric modulatory sites on isoforms of GABA(A) receptors which are crucial for the regulation of arousal and have recently been implicated in the circadian control of physiological sleep.Keywords
This publication has 38 references indexed in Scilit:
- Modulation of a recombinant invertebrate γ‐aminobutyric acid receptor‐chloride channel complex by isoflurane: effects of a point mutation in the M2 domainBritish Journal of Pharmacology, 1997
- Transmitter timecourse in the synaptic cleft: its role in central synaptic functionTrends in Neurosciences, 1996
- Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’FEBS Letters, 1995
- Circadian time‐dependent modulation of sleep and brain temperature (Tbr) by methylcobalamine and resultant prolongation of Tbr freerunning period in ratsBiological Rhythm Research, 1995
- Chemical Characterization of a Family of Brain Lipids That Induce SleepScience, 1995
- GABA receptors, granule cells and genesNature, 1993
- Ethanol potentiation of GABAA receptors requires phosphorylation of the alternatively spliced variant of the γ2 subunitFEBS Letters, 1992
- Cellular Mechanisms of AnesthesiaaAnnals of the New York Academy of Sciences, 1991
- Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious ratsBiochemical and Biophysical Research Communications, 1982
- Localizing 3H-GABA in Nerve Terminals of Rat Cerebral Cortex by Electron Microscopic AutoradiographyNature, 1971